Beacon Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Beacon Trust's ABBV Position: Q1 2017 in Review
Beacon Trust increased its AbbVie (ABBV) stake by 0.85% in Q1 2017, buying an estimated $74.1K and bringing the position to 139,416 shares worth $8.62M. The position accounts for 1.36% of the portfolio, ranked #19.
Beacon Trust first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $9.78M in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.
- Beacon Trust held 139,416 shares of AbbVie worth $8.62M as of Q1 2017.
- Beacon Trust bought 1,178 AbbVie shares in Q1 2017, an estimated $74.1K.
- AbbVie made up 1.36% of Beacon Trust's portfolio in Q1 2017, its #19 holding.
- Beacon Trust first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
- Beacon Trust's AbbVie position peaked at $9.78M in Q2 2015.
- 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.
Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.